Does prostaglandin D2 hold the cure to male pattern baldness?

Area of Science:

• Dermatology and biochemistry of skin lipids.
• Molecular mechanisms of hair growth regulation.

Background:

• Skin lipids are diverse, with largely unexplored roles in health and disease.
• Prostaglandin D2 (PGD2) is implicated in androgenetic alopecia (AGA), a common form of hair loss.
• PGD2 is synthesized by prostaglandin D2 synthase (PTGDS) and acts on GPR44 and PTGDR receptors.

Purpose of the Study:

• To review current knowledge on PGD2's role in AGA.
• To explore the potential of targeting the PGD2 pathway for novel AGA therapies.

Main Methods:

• Literature review of studies on PGD2, PTGDS, and GPR44 in the context of hair biology.
• Analysis of the molecular pathways involved in PGD2-mediated hair growth inhibition.

Main Results:

• Elevated PGD2 levels in bald scalps of men with AGA.
• PGD2 significantly decreases hair lengthening.
• GPR44 receptor is essential for PGD2's effect on hair growth.

Conclusions:

• PGD2 and its receptor GPR44 are key players in the pathogenesis of AGA.
• Inhibiting PTGDS, PGD2, or GPR44 presents a promising therapeutic strategy for treating hair loss.